Theranostics 2021; 11(5):2079. doi:10.7150/thno.56734 This issue Cite

Erratum

TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis: Erratum

Han-Li Huang1,2, Yi-Min Liu1, Ting-Yi Sung2, Tsui-Chin Huang3, Ya-Wen Cheng3, Jing-Ping Liou1,4,✉, Shiow-Lin Pan1,2,3,✉

1. TMU Biomedical Commercialization Center, Taipei Medical University, Taipei 11031, Taiwan
2. Ph.D Program in Biotechnology Research and Development, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
3. Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
4. School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.

Citation:
Huang HL, Liu YM, Sung TY, Huang TC, Cheng YW, Liou JP, Pan SL. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis: Erratum. Theranostics 2021; 11(5):2079. doi:10.7150/thno.56734. https://www.thno.org/v11p2079.htm
Other styles

File import instruction

Corrected-article in Theranostics, Volume 9, 6676


Citation styles

APA
Huang, H.L., Liu, Y.M., Sung, T.Y., Huang, T.C., Cheng, Y.W., Liou, J.P., Pan, S.L. (2021). TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis: Erratum. Theranostics, 11(5), 2079. https://doi.org/10.7150/thno.56734.

ACS
Huang, H.L.; Liu, Y.M.; Sung, T.Y.; Huang, T.C.; Cheng, Y.W.; Liou, J.P.; Pan, S.L. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis: Erratum. Theranostics 2021, 11 (5), 2079. DOI: 10.7150/thno.56734.

NLM
Huang HL, Liu YM, Sung TY, Huang TC, Cheng YW, Liou JP, Pan SL. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis: Erratum. Theranostics 2021; 11(5):2079. doi:10.7150/thno.56734. https://www.thno.org/v11p2079.htm

CSE
Huang HL, Liu YM, Sung TY, Huang TC, Cheng YW, Liou JP, Pan SL. 2021. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis: Erratum. Theranostics. 11(5):2079.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image